Abstract
Overview
Introduction
The ageing of the population will result in an increased incidence of coronary
artery disease, heart failure and stroke. In addition to these epidemiological
forces, the antithrombotics market will be sustained by the forthcoming launch
of innovative novel agents whose sales revenue is expected to dampen the
commercial impact of generic incursion in blockbuster proceeds.
Scope
- Country specific event-driven sales forecasts for the period 2006-15 for
the US, Japan, France, Germany, Italy, Spain and the UK.
- Discussion of recent trials and market-shaping future key events.
- Profiles of the country and market specific issues which will impact
future sales in the market including generic erosion and class switching.
- Case studies evaluating the commercial impact of two developmental agents
with blockbuster potential.
Report Highlights
Demographic trends lead to an increase in the patient population requiring
antithrombotic therapy. However, the rising age of the population across all
developed regions is increasing the fiscal burden on healthcare payors which
are likely to respond by limiting the reimbursement potential of therapies and
put pricing pressure on all agents.
The highest selling brands in the antidiabetics market are Lovenox
(enoxaparin) and Plavix (clopidogrel), but these agents are subject to
forthcoming genericization and will thus not contribute to the growth of the
antithrombotics market in the medium-to-long term. Pipeline agents are
expected to become significant drivers in the market.
The antithrombotics market is characterized by pockets of high unmet need and
a broad spectrum of similarly efficacious therapeutic strategies. There is
regional bias in the choice and popularity of therapeutic strategies driven by
cultural reasons as well as infrastructural confines.
Reasons to Purchase
- Quantify future size and scope of the antithrombotics market and potential
for new products
- Analyze options to expand commercial potential through pursuit of new
indications
- Formulate successful launch strategies in a highly competitive mature
market
View Cart
